位置:首页 > 蛋白库 > PLCG_CAEEL
PLCG_CAEEL
ID   PLCG_CAEEL              Reviewed;        1350 AA.
AC   Q22070;
DT   05-OCT-2016, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma plc-3 {ECO:0000305};
DE            EC=3.1.4.11 {ECO:0000255|RuleBase:RU361133};
DE   AltName: Full=Phosphoinositide phospholipase C-gamma plc-3 {ECO:0000305};
DE   AltName: Full=Phospholipase C-gamma plc-3 {ECO:0000305};
DE            Short=PLC-gamma plc-3 {ECO:0000305};
GN   Name=plc-3 {ECO:0000312|WormBase:T01E8.3};
GN   ORFNames=T01E8.3 {ECO:0000312|WormBase:T01E8.3};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=15194811; DOI=10.1091/mbc.e04-03-0198;
RA   Yin X., Gower N.J., Baylis H.A., Strange K.;
RT   "Inositol 1,4,5-trisphosphate signaling regulates rhythmic contractile
RT   activity of myoepithelial sheath cells in Caenorhabditis elegans.";
RL   Mol. Biol. Cell 15:3938-3949(2004).
RN   [3] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=16186564; DOI=10.1085/jgp.200509355;
RA   Espelt M.V., Estevez A.Y., Yin X., Strange K.;
RT   "Oscillatory Ca2+ signaling in the isolated Caenorhabditis elegans
RT   intestine: role of the inositol-1,4,5-trisphosphate receptor and
RT   phospholipases C beta and gamma.";
RL   J. Gen. Physiol. 126:379-392(2005).
RN   [4] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=15958491; DOI=10.1091/mbc.e05-02-0096;
RA   Gower N.J., Walker D.S., Baylis H.A.;
RT   "Inositol 1,4,5-trisphosphate signaling regulates mating behavior in
RT   Caenorhabditis elegans males.";
RL   Mol. Biol. Cell 16:3978-3986(2005).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=17891142; DOI=10.1038/nn1981;
RA   Van Buskirk C., Sternberg P.W.;
RT   "Epidermal growth factor signaling induces behavioral quiescence in
RT   Caenorhabditis elegans.";
RL   Nat. Neurosci. 10:1300-1307(2007).
RN   [6] {ECO:0000305}
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=18604269; DOI=10.1371/journal.pgen.1000117;
RA   Gruninger T.R., Gualberto D.G., Garcia L.R.;
RT   "Sensory perception of food and insulin-like signals influence seizure
RT   susceptibility.";
RL   PLoS Genet. 4:E1000117-E1000117(2008).
RN   [7] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18369461; DOI=10.1371/journal.pgen.1000043;
RA   Vazquez-Manrique R.P., Nagy A.I., Legg J.C., Bales O.A., Ly S.,
RA   Baylis H.A.;
RT   "Phospholipase C-epsilon regulates epidermal morphogenesis in
RT   Caenorhabditis elegans.";
RL   PLoS Genet. 4:E1000043-E1000043(2008).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19380113; DOI=10.1016/j.chom.2009.03.006;
RA   Ziegler K., Kurz C.L., Cypowyj S., Couillault C., Pophillat M., Pujol N.,
RA   Ewbank J.J.;
RT   "Antifungal innate immunity in C. elegans: PKCdelta links G protein
RT   signaling and a conserved p38 MAPK cascade.";
RL   Cell Host Microbe 5:341-352(2009).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19730689; DOI=10.1371/journal.pgen.1000636;
RA   Walker D.S., Vazquez-Manrique R.P., Gower N.J., Gregory E., Schafer W.R.,
RA   Baylis H.A.;
RT   "Inositol 1,4,5-trisphosphate signalling regulates the avoidance response
RT   to nose touch in Caenorhabditis elegans.";
RL   PLoS Genet. 5:E1000636-E1000636(2009).
RN   [10] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19923421; DOI=10.1152/ajpcell.00394.2009;
RA   Xing J., Strange K.;
RT   "Phosphatidylinositol 4,5-bisphosphate and loss of PLCgamma activity
RT   inhibit TRPM channels required for oscillatory Ca2+ signaling.";
RL   Am. J. Physiol. 298:C274-C282(2010).
CC   -!- FUNCTION: Mediates the production of the second messenger molecules
CC       diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) which plays
CC       an important role in the regulation of intracellular signaling cascades
CC       (Probable). Regulates basal and ovulatory sheath cell contractions by
CC       controlling Ca(2+) oscillations via IP3-mediated activation of IP3
CC       receptor itr-1 (PubMed:15194811). In intestinal epithelial cells,
CC       regulates Ca(2+) oscillations which control posterior body wall muscle
CC       contractions required for defecation by IP3-mediated activation of itr-
CC       1 and probably by activating TRPM channels gon-2 and gtl-1 by reducing
CC       PIP2 levels (PubMed:19923421, PubMed:16186564). By activating tpa-1 via
CC       DAG production, required for the expression of antimicrobial peptide
CC       nlp-29 in the epidermis in response to fungal infection or physical
CC       injury (PubMed:19380113). By triggering Ca(2+) transient via IP3-
CC       mediated activation of IPR3 receptor itr-1 in ASH sensory neurons,
CC       involved in avoidance behavior in response to nose touch
CC       (PubMed:19730689). Probably by regulating neuronal transmission in ALA
CC       neurons, mediates the decrease in pharyngeal pumping and locomotion
CC       during the quiescent state that precedes each larval molt, downstream
CC       of lin-3 and receptor let-23 and upstream of tpa-1 but not itr-1
CC       (PubMed:17891142). During embryogenesis, may play an role in epidermal
CC       morphogenesis together with plc-1 (PubMed:18369461). Probably
CC       downstream of receptor daf-2, regulates male-sex muscle excitability in
CC       the absence of food (PubMed:18604269). {ECO:0000269|PubMed:15194811,
CC       ECO:0000269|PubMed:16186564, ECO:0000269|PubMed:17891142,
CC       ECO:0000269|PubMed:18369461, ECO:0000269|PubMed:18604269,
CC       ECO:0000269|PubMed:19380113, ECO:0000269|PubMed:19730689,
CC       ECO:0000269|PubMed:19923421, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-
CC         diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456,
CC         ChEBI:CHEBI:203600; EC=3.1.4.11;
CC         Evidence={ECO:0000255|RuleBase:RU361133};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Expressed in intestine, isthmus of the pharynx,
CC       proximal gonad sheath cells, spermatheca and uterine sheath cells
CC       (PubMed:15194811, PubMed:16186564). In males, expressed in the valve
CC       cell, the vas deferens and retractor and ventral protactor muscles
CC       (PubMed:15958491, PubMed:18604269). {ECO:0000269|PubMed:15194811,
CC       ECO:0000269|PubMed:15958491, ECO:0000269|PubMed:16186564,
CC       ECO:0000269|PubMed:18604269}.
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes sterility
CC       resulting from impaired spermatheca dilatation causing a defect in
CC       ovulation, and a severe decrease in sheath cell basal and peak
CC       ovulatory contractions (PubMed:15194811, PubMed:18369461). The few
CC       embryos laid are arrested at the embryonic stage (PubMed:18369461).
CC       Cycles of posterior body wall muscle contractions are prolonged and
CC       arrhythmic resulting in a defecation defect (PubMed:16186564). Ca(2+)
CC       oscillations in intestinal cells are arrhythmic and the whole cell
CC       current amplitude is severely reduced (PubMed:16186564,
CC       PubMed:19923421). RNAi-mediated knockdown in males causes an increase
CC       in spontaneous muscle seizures in the absence of food in an unc-103
CC       mutant background (PubMed:18604269). Ca(2+) transient increase and
CC       avoidance behavior are defective in response to nose touch but not to
CC       benzaldehyde (PubMed:19730689). nlp-29 expression is abrogated
CC       following fungal infection by D.coniospora and severely reduced
CC       following physical injury (PubMed:19380113).
CC       {ECO:0000269|PubMed:15194811, ECO:0000269|PubMed:16186564,
CC       ECO:0000269|PubMed:18369461, ECO:0000269|PubMed:18604269,
CC       ECO:0000269|PubMed:19380113, ECO:0000269|PubMed:19730689,
CC       ECO:0000269|PubMed:19923421}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284602; CAA88745.2; -; Genomic_DNA.
DR   RefSeq; NP_496205.2; NM_063804.4.
DR   AlphaFoldDB; Q22070; -.
DR   SMR; Q22070; -.
DR   IntAct; Q22070; 2.
DR   STRING; 6239.T01E8.3; -.
DR   EPD; Q22070; -.
DR   PaxDb; Q22070; -.
DR   PeptideAtlas; Q22070; -.
DR   PRIDE; Q22070; -.
DR   EnsemblMetazoa; T01E8.3.1; T01E8.3.1; WBGene00004038.
DR   GeneID; 174586; -.
DR   KEGG; cel:CELE_T01E8.3; -.
DR   UCSC; T01E8.3; c. elegans.
DR   CTD; 174586; -.
DR   WormBase; T01E8.3; CE42905; WBGene00004038; plc-3.
DR   eggNOG; KOG1264; Eukaryota.
DR   GeneTree; ENSGT00940000169016; -.
DR   HOGENOM; CLU_002738_5_0_1; -.
DR   InParanoid; Q22070; -.
DR   OMA; SLDCYAQ; -.
DR   OrthoDB; 368239at2759; -.
DR   PhylomeDB; Q22070; -.
DR   Reactome; R-CEL-114604; GPVI-mediated activation cascade.
DR   Reactome; R-CEL-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-CEL-1855204; Synthesis of IP3 and IP4 in the cytosol.
DR   Reactome; R-CEL-186763; Downstream signal transduction.
DR   Reactome; R-CEL-202433; Generation of second messenger molecules.
DR   Reactome; R-CEL-210990; PECAM1 interactions.
DR   Reactome; R-CEL-212718; EGFR interacts with phospholipase C-gamma.
DR   Reactome; R-CEL-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-CEL-5621480; Dectin-2 family.
DR   Reactome; R-CEL-5654219; Phospholipase C-mediated cascade: FGFR1.
DR   Reactome; R-CEL-5654228; Phospholipase C-mediated cascade, FGFR4.
DR   PRO; PR:Q22070; -.
DR   Proteomes; UP000001940; Chromosome II.
DR   Bgee; WBGene00004038; Expressed in pharyngeal muscle cell (C elegans) and 3 other tissues.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:UniProtKB-EC.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0009395; P:phospholipid catabolic process; IEA:InterPro.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; IBA:GO_Central.
DR   GO; GO:0030431; P:sleep; IMP:WormBase.
DR   CDD; cd09932; SH2_C-SH2_PLC_gamma_like; 1.
DR   CDD; cd10341; SH2_N-SH2_PLC_gamma_like; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 2.
DR   Gene3D; 3.30.505.10; -; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR016279; PLC-gamma.
DR   InterPro; IPR035023; PLC-gamma_C-SH2.
DR   InterPro; IPR035024; PLC-gamma_N-SH2.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00018; SH3_1; 1.
DR   PIRSF; PIRSF000952; PLC-gamma; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SMART; SM00252; SH2; 2.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Hydrolase; Lipid degradation; Lipid metabolism; Metal-binding;
KW   Reference proteome; Repeat; SH2 domain; SH3 domain; Transducer.
FT   CHAIN           1..1350
FT                   /note="1-phosphatidylinositol 4,5-bisphosphate
FT                   phosphodiesterase gamma plc-3"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000437463"
FT   DOMAIN          352..503
FT                   /note="PI-PLC X-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   DOMAIN          605..704
FT                   /note="SH2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          715..804
FT                   /note="SH2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          832..890
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          855..960
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          982..1092
FT                   /note="PI-PLC Y-box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00271"
FT   DOMAIN          1099..1220
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..40
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          570..594
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1270..1350
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1285..1332
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        367
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
FT   ACT_SITE        419
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00270"
SQ   SEQUENCE   1350 AA;  154574 MW;  8F636BE56E7F58F1 CRC64;
     MQHGSLGPSS SSRKTTVTST AGSVHLHHRS SNGFSTASRA QLNRHNEMDF GKMFAAMEKG
     HKVCKIAVLK KWDPAYKQLT LDRYSRQIFL TKLELSAVRN KPTILDIRQI REVQTLNYKL
     NTIKVDDKWK KDREIVNFDS KAILIISYGM GFALSYWILL FESEDACKLW SQGLHNLMMD
     TRDRDSSPHP LRIERFLHKH FLSLMSPAND AVARKHMKPF VQTSLQFKVQ SDQLQQVTED
     QMNSDQFSFA SRQLIHVPEL FSSRFADLAE KHERKGLVVT FQNFLRFLDG KQFDELASNR
     TRALEFLNRY FQEDQAYFGD RNEPSMTVFE FCDFLFSREN SLWDPTNEKV THDMSRPLSH
     YWIASSHNTY LTGDQLRSES SLDCYAQALL MGCRCIELDC WDGQKKPGSA EFIDIVIYHG
     YTMTSKILLR DVLHVIRHYA FVTSEYPVIL SIEDNCSVPA QRLLAQELKD ILGDYLLTQP
     ANREEKQLPS PAALKKKIIV KHKKLPIESE DLAAVVKTDE FQDTEIISRE CVKKGILMVK
     NNNSHEWTSH VFILFPDRLC YLIQTADPEN PNDDTVSVSG DEEREEETPS GFGVKPEEMH
     VTEEWFHGRC ERDEAKKRIL EHKEKGNGLF MIRDSNLFIG DFSLSILHDG KVHHVRIRSK
     IIDKEKKYYF MDNKVCDTLY ELVSYYTRHY LTTAHFKMVL TIPCPQPQPH LNQPWFSATA
     DKEKAEELLS LVPEDGAFLI RTSSTDSSVY VLSLKVDGEF WHYRLKRDGR IFVVNQKVFE
     NLNQIVEFYA NREFVRGISL RFPVNEKDIS HLTAELAEAR TPGCYMDLKD LDKEVQARAL
     RPYRGTADDE LSFPANVIIT VLRKEEGLWR GRYGSLTGWF PSAHVQEILP EKVSTSETSN
     YNTIELAGTL IERIHDADRP NVIRISQSNQ HWMNKQYYLL AASSSEEADG WQNNLFELTR
     SVNTKMSILR TKEKEKRIAA ELSNLVVYCQ AVPFDPAHIY NDAFYEMCSF VEGKLDKLVE
     KGLLPFNSRK LSRVYPNGSR ITSNNYSPVP MWNAGCHMVA LNYQTGDKPM QLNQGKFLAN
     GRCGYLLKPD YMLTDDFDPT NTEKFATAYP IRLNVQVIGG RHLSRKDKNK GICSPFVEIE
     IIGMPCDTKV FQTKTIASNG LNPIWNQTFT FEIQCPEVAL IRFHVEDGDF VGPKTDPFIG
     QAVFPVDSIR CGFRSVPLKN QYSEELELSS LLVDVQMCSR EGTQLIRSSS HFLQASRLAP
     VFAHRKITNG DSIPREMAPR LRTSATDRSL DSPTNSESRA TLLSGQRGSQ DSMDSAAETS
     SIASGTISSR DGKKKQNWLK KFSFGKSSKS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024